UNIVERSITY OF WASHINGTON
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 1861-01-01
- Employees
- 10K
- Market Cap
- -
Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T
Phase 2
Recruiting
- Conditions
- Recurrent Diffuse Large B-Cell LymphomaRecurrent Primary Mediastinal Large B-Cell LymphomaRecurrent Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Grade 3b Follicular LymphomaRecurrent High Grade B-Cell LymphomaRecurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRefractory Grade 3b Follicular LymphomaRefractory High Grade B-Cell Lymphoma
- Interventions
- Procedure: Biospecimen CollectionProcedure: Bone Marrow AspirationProcedure: Bone Marrow BiopsyProcedure: Computed TomographyProcedure: LeukapheresisProcedure: Lumbar PunctureProcedure: Positron Emission TomographyOther: Questionnaire AdministrationProcedure: Biopsy
- First Posted Date
- 2025-01-20
- Last Posted Date
- 2025-06-19
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 27
- Registration Number
- NCT06784726
- Locations
- πΊπΈ
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
A Digital Health Intervention to Improve Symptoms and Physical Activity During Breast Radiation
Not Applicable
Recruiting
- Conditions
- Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Breast Carcinoma
- First Posted Date
- 2025-01-13
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 30
- Registration Number
- NCT06772181
- Locations
- πΊπΈ
MultiCare Valley Hospital (Spokane), Spokane Valley, Washington, United States
πΊπΈFred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data
Not Applicable
Recruiting
- Conditions
- Opioid Use DisorderOpioid Use
- First Posted Date
- 2025-01-10
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 40000
- Registration Number
- NCT06768814
- Locations
- πΊπΈ
Downtown Emergency Service Center's Overdose Recovery and Care Access Centers, Seattle, Washington, United States
Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma
Phase 2
Recruiting
- Conditions
- Advanced Hodgkin LymphomaClassic Hodgkin LymphomaLugano Classification Stage III Hodgkin Lymphoma AJCC v8Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8
- Interventions
- Procedure: Biospecimen CollectionProcedure: Computed TomographyProcedure: Echocardiography TestProcedure: Multigated Acquisition ScanProcedure: Positron Emission TomographyOther: Questionnaire
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 125
- Registration Number
- NCT06745076
- Locations
- πΊπΈ
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Hybrid Type-1 Effectiveness-Implementation Trial of Motivation Matters!
Not Applicable
Not yet recruiting
- Conditions
- HIV Antiretroviral Therapy (ART) Adherence
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 350
- Registration Number
- NCT06745050
- Locations
- π°πͺ
Partner for Health and Development in Africa, Nairobi, Kenya
The Impact of an Evidence-Based Parenting Service on Maternal Sensitivity and Infant Cellular Aging in a Population of Under-Resourced Families
Not Applicable
Recruiting
- Conditions
- Parent Child RelationshipChild Social-Emotional DevelopmentTelomere LengthEpigenetic Aging
- First Posted Date
- 2024-12-18
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 250
- Registration Number
- NCT06740266
- Locations
- πΊπΈ
WakeMed Health & Hospitals, Raleigh, North Carolina, United States
Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
Phase 2
Not yet recruiting
- Conditions
- B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeT Acute Lymphoblastic Leukemia
- Interventions
- Procedure: Biospecimen CollectionProcedure: Bone Marrow CollectionProcedure: Computed TomographyProcedure: Positron Emission Tomography
- First Posted Date
- 2024-12-17
- Last Posted Date
- 2025-06-05
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 30
- Registration Number
- NCT06738368
- Locations
- πΊπΈ
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Brief Interventions to Reduce Comorbid Alcohol and Cannabis Misuse and Sleep Impairment in Young Adults (Rest-Up RCT)
Not Applicable
Not yet recruiting
- Conditions
- InsomniaAlcohol UseMarijuana Use
- First Posted Date
- 2024-12-16
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 800
- Registration Number
- NCT06736444
Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.
Active, not recruiting
- Conditions
- Retinoblastoma BilateralRetinoblastoma UnilateralRetinoblastoma, ExtraocularRetinoblastoma, RecurrentRetinoblastoma
- First Posted Date
- 2024-12-10
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 100
- Registration Number
- NCT06725173
- Locations
- πΊπΈ
University of Washington, Seattle, Washington, United States
Stroke and CPAP Outcome Study 3 Randomized Controlled Trial
Not Applicable
Recruiting
- Conditions
- Stroke PatientsCPAPOSA - Obstructive Sleep Apnea
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 250
- Registration Number
- NCT06722755
- Locations
- πΊπΈ
Rancho Research Institute, Downey, California, United States
πΊπΈUniversity of Washington - Harborview Medical Center, Seattle, Washington, United States